ZIPZOC %v/v Impregnated Dressing
Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Vara einkenni
(SPC)
19-10-2016
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
ZINC OXIDE
Fáanlegur frá:
Smith & Nephew Pharmaceuticals
ATC númer:
D09AB01
INN (Alþjóðlegt nafn):
ZINC OXIDE
Skammtar:
%v/v
Lyfjaform:
Impregnated Dressing
Gerð lyfseðils:
Product subject to prescription which may be renewed (B)
Lækningarsvæði:
Zinc bandages
Leyfisstaða:
Transfer Pending
Leyfisdagur:
1998-07-13
Vara einkenni
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Zipzoc 20%, Impregnated Dressing
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
20 % Zinc Oxide
Each stocking (80 cm x 7 cm) contains about 41.5g of ointment
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Impregnated dressing.
Zipzoc is a sterile rayon stocking impregnated with an ointment containing Zinc Oxide.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
To be used as an aid in the treatment of chronic leg ulcers. Where chronic venous insufficiency exists the stocking can
be used as a primary contact layer under compression bandaging or hosiery.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For cutaneous use.
Zipzoc should be applied to cover the lower leg from the base of the toes to below the knee. All folds should be
smoothed out. To protect clothes from Zipzoc a suitable outer bandage should be worn. If chronic venous insufficiency
exists, Zipzoc can be used as a primary contact layer under suitable compression bandaging.
The duration and frequency of application will depend on the clinical circumstances, but Zipzoc must be changed no
less frequently than weekly.
4.3 CONTRAINDICATIONS
Arterial leg ulcers.
Known hypersensitivity to zinc oxide or the excipients in the ointment.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If the outer bandage is inappropriate or the stocking is not changed with sufficient frequency it can cause the stocking
to dry out.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None known
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 04/10/2016_
_CRN 2181958_
_page number: 1_
4.6 FERTILITY, PREGNANCY AND LACTATION
There is no evid
Lestu allt skjalið
